483 Document: Novartis Pharmaceuticals Corporation, Aug 21, 2023

FDANews 483 Novartis Pharmaceuticals Corporation Aug 21 2023 top
Tyanna N. Hadley FDA Investigator Mayar M. Mussa FDA Investigator

On Aug 21, 2023, the FDA inspected Novartis Pharmaceuticals Corporation's East Hanover site. Explore the inspectional observations.